MiMedx Signs Definitive Agreement to Divest Stability Biologics Subsidiary For $3.5M Promissory Note And Waiver By Former Stockholders Of Stability Of All Claims, Rights To Earn-Out Consideration; Co. Expects To Book One-Time Gain Of $8-10M
Paul Quintaro